President Trump took Big Pharma to task on pricing but also promised to ease regulations and find ways to speed medicines to market, which triggered a surge in the sector’s share prices.
Given his background, it’s not surprising that President Donald Trump gravitates to strong leaders. Many of his cabinet nominees served as either private-sector CEOs or military generals, executives with strong personalities and substantial experience at the top of large organizations. Closer to home, Indiana Gov. Eric Holcomb has selected some top aides from the private […]
The drug industry spends $5 billion a year pitching its pills and ointments to consumers. But it still finds itself on the defensive over high prices, so an industry group is trying to rescue its image.
The Indianapolis-based drugmaker’s purchase of the biotech firm CoLucid Pharmaceuticals will give it access to a late-stage experimental medication for migraine headaches.
The not-for-profits, some of which received as much as $10 million, include community centers, hunger relief agencies and social services groups. Most plan to use at least a portion of the money to create or fortify endowments.
Purdue University Professor You-Yeon Won’s development, called radio-luminescent nanoparticles, is designed to enhance the cancer-cell-killing effects of radiation treatment.
An iconic architectural landmark that would create a gateway to downtown is one of several features city officials want as part of a redevelopment of the former General Motors stamping plant site.
Teva Pharmaceuticals Industries Ltd.’s proposed generic version infringes a patent on the multi-billion-dollar patent, the U.S. Court of Appeals for the Federal Circuit ruled.
Eric Holcomb was a struggling Republican Senate candidate a year ago, a virtual unknown in Indiana despite more than a decade at the top levels of the Republican state politics. On Monday, he became Indiana’s chief executive.
Jim Schellinger, the incoming secretary of commerce, previously was president of the Indiana Economic Development Corp., a role that included frequent travel to communities across the state. In his new post, he'll be courting companies across the globe.
Alex Azar, president of Lilly USA LLC since 2012, is leaving the company just as his unit is about to lose a huge swath of sales personnel. The drugmaker announced a series of changes Thursday under new CEO David Ricks.
It was the year of the improbable, especially in politics—starting with the resignation of Lt. Gov. Sue Ellspermann and ending with the election of Mike Pence as vice president. Then there was Carrier’s flip-flip, Eli Lilly’s changing of the guard, ITT Educational Services’ collapse—and much, much more.
One can argue that 200 years is the blink of an eye in the transcript of history. It’s remarkable to observe the progress that has transpired in Indiana since statehood was achieved in 1816.
t was the most closely watched experimental drug from Eli Lilly and Co. in years, a potential game-changer for treating the ravages of Alzheimer’s disease.
Young professional boards, usually consisting of members ages 21 to 40, vary in size and responsibilities, but the groups are seen as a way to engage millennials.
